Antibiotic-Associated Diarrhea Clinical Trial
Official title:
Prospective, Randomized Study of Oral Metronidazole vs. Oral Metronidazole and Rifampin for Treatment of Clostridium Difficile-associated Diarrhea (CDAD)
What is the difference between the use of one drug (Oral Metronidazole) versus the use of this same drug combined with another drug (Rifampin) in treatment of bacteria and infection-associated diarrhea in patients? This infection is an important cause of morbidity and mortality in both the community and hospitals, and the leading cause of hospital and chronic facility-acquired diarrhea. Research is important for the treatment of this infection. Patient care with use of two medication treatment regimens will be studied.
Clostridium difficile infection contributes to both community and hospital acquired morbidity and mortality. Metronidazole alone is usually considered the drug of choice, however, frequent relapses occur at a rate of 10-40%. The purpose of this study is to address the use of a combined drug regimen treatment (Metronidazole and Rifampin) for the treatment of CDAD. These drugs used together have been successful. Objectives are to determine the time (days) to resolution of symptoms in each treatment arm; to measure clinical relapse rates; and to assess adverse reactions related to treatment. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03181516 -
Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics
|
Phase 2 | |
Recruiting |
NCT03895593 -
Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections
|
||
Completed |
NCT00382304 -
A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea
|
Phase 2 | |
Completed |
NCT04212403 -
Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)
|
N/A | |
Terminated |
NCT02900196 -
Effect of a Fresh Fermented Dairy Drink Product Consumption on Antibiotic Associated Diarrhea and Gastro-Intestinal Disorders
|
N/A | |
Completed |
NCT01782755 -
Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial
|
Phase 2 | |
Completed |
NCT06109740 -
Probiotics For The Prevention of Antibiotics Associated Diarrhea in the Pediatric Intensive Care Unit
|
N/A | |
Suspended |
NCT00591357 -
Efficacy of Loperamide for C. Difficile Colitis and Other Diarrheal Diseases Associated With Antibiotic Therapy
|
Phase 4 | |
Completed |
NCT00700557 -
Probiotics at the Treatment of Antibiotic Associated Diarrhea
|
Phase 4 | |
Active, not recruiting |
NCT03256708 -
Prevention of Antibiotic-Associated Diarrhoea With Prolardii
|
N/A | |
Completed |
NCT04321460 -
Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults.
|
Phase 3 | |
Completed |
NCT05607056 -
Efficacy and Safety of Sinquanon for Prevention of Antibiotic-associated Diarrhea in Adults
|
N/A | |
Recruiting |
NCT05845073 -
The Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms
|
N/A | |
Completed |
NCT02127814 -
Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile
|
N/A | |
Completed |
NCT01143623 -
Dose Response Effect of Probiotics for the Prevention of Antibiotic-associated Diarrhea in Chinese Adults
|
Phase 2/Phase 3 | |
Completed |
NCT00641199 -
Probiotics for Prevention of Antibiotic-associated Diarrhea
|
N/A | |
Completed |
NCT02462590 -
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial
|
Phase 4 | |
Terminated |
NCT01143272 -
Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea
|
Phase 3 | |
Completed |
NCT03755765 -
Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics
|
Early Phase 1 | |
Completed |
NCT05990972 -
Clinical Study of Fecal Microbiota Transplantation in the Treatment of Antibiotic-associated Diarrhea
|
N/A |